| Phytosome: A brief overview S Saha, A Sarma, P Saikia, T Chakrabarty Scholars academic journal of pharmacy 2 (1), 12-20, 2013 | 42 | 2013 |
| Nano-ART and neuroAIDS MK Das, A Sarma, T Chakraborty Drug Delivery and Translational Research 6, 452-472, 2016 | 29 | 2016 |
| Biological importance and pharmaceutical significance of keratin: A review A Sarma International Journal of Biological Macromolecules 219, 395-413, 2022 | 27 | 2022 |
| Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS A Sarma, MK Das Molecular biomedicine 1, 1-23, 2020 | 24 | 2020 |
| Therapeutic nanostructures and nanotoxicity A Sarma, R Bania, JR Devi, S Deka Journal of Applied Toxicology 41 (10), 1494-1517, 2021 | 21 | 2021 |
| Formulation by Design (FbD) approach to develop Tenofovir Disoproxil Fumarate loaded Nanostructured Lipid Carriers (NLCs) for the aptness of nose to brain delivery A Sarma, MK Das Journal of Drug Delivery and Therapeutics 9 (2), 148-159, 2019 | 18 | 2019 |
| Nanostructured lipid carriers (NLCs)-based intranasal Drug Delivery System of Tenofovir disoproxil fumerate (TDF) for brain targeting A Sarma, MK Das, T Chakraborty, S Das Res. J. Pharm. Technol 13, 5411-5424, 2020 | 14 | 2020 |
| PLGA-derived anticancer Nano therapeutics Promises and challenges for the future ASTC Malay K. Das Journal of Chemical and Pharmaceutical Research 8 (2), 484-499, 2016 | 13 | 2016 |
| Bilayer tablet and duredas technology–a review A Sarma, P Deb, S Dash International Journal of Pharmacy and Biological Sciences 3 (2), 554-563, 2013 | 11 | 2013 |
| Successful delivery of zidovudine-loaded docosanol nanostructured lipid carriers (docosanol NLCs) into rat brain T Chakraborty, MK Das, L Dutta, B Mukherjee, S Das, A Sarma Surface modification of nanoparticles for targeted drug delivery, 245-276, 2019 | 10 | 2019 |
| Green tea: Current trends and prospects in nutraceutical and pharmaceutical aspects A Sarma, R Bania, MK Das Journal of Herbal Medicine, 100694, 2023 | 8 | 2023 |
| Unveiling the promise: Exosomes as game‐changers in anti‐infective therapy VP Chavda, G Luo, R Bezbaruah, T Kalita, A Sarma, G Deka, Y Duo, ... Exploration, 20230139, 2024 | 7 | 2024 |
| Improving the sustainable performance of Biopolymers using nanotechnology A Sarma, MK Das Polymer-Plastics Technology and Materials 60 (18), 1935-1965, 2021 | 7 | 2021 |
| Formulation and evaluation of ethambutol polymeric nanoparticles M Hussain, A SARMA, SS RAHMAN, AM SIDDIQUE, TP EESWARI International Journal of Applied Pharmaceutics, 207-217, 2020 | 7 | 2020 |
| Polydopamine-based simple and versatile surface modification of polymeric nano drug carriers MK Das, A Sarma, T Deka Surface modification of nanoparticles for targeted drug delivery, 369-389, 2019 | 6 | 2019 |
| Exosome: From biology to drug delivery H Baruah, A Sarma, D Basak, M Das Drug delivery and translational research, 1-37, 2024 | 5 | 2024 |
| Variant influenza: connecting the missing dots V Chavda, R Bezbaruah, T Kalita, A Sarma, JR Devi, R Bania, ... Expert Review of Anti-infective Therapy 20 (12), 1567-1585, 2022 | 2 | 2022 |
| Toxicity of nanostructures and nanodrugs T Chakraborty, A Sarma Phytoantioxidants and Nanotherapeutics, 267-287, 2022 | 2 | 2022 |
| Silk fibroin: A smart biomaterial for long term and targeted nanotherapeutics T Chakraborty, A Sarma, MK Das Curr. Trends 3, 45-82, 2016 | 2 | 2016 |
| Nanocosmeceuticals: Current trends, market analysis, and future trends A Sarma, T Chakraborty, MK Das Nanocosmeceuticals, 525-558, 2022 | 1 | 2022 |
